
-
In Simandou mountains, Guinea prepares to cash in on iron ore
-
Morikawa says not to blame for 'rude' Ryder Cup fans
-
Far right harvests votes as climate rules roil rural Spain
-
'Return to elegance': highlights from Paris Fashion Week
-
Britain's storied Conservative party faces uncertain future
-
New Zealand's seas warming faster than global average: report
-
Snakebite surge as Bangladesh hit by record rains
-
Yankees deny Blue Jays playoff sweep as Mariners beat Tigers
-
Australia police foil 'kill team' gang hit near daycare centre
-
US, Qatar, Turkey to join third day of Gaza peace talks in Egypt
-
Gold tops $4,000 for first time as traders pile into safe haven
-
Indian garment exporters reel under US tariffs
-
NBA back in China after six-year absence sparked by democracy tweet
-
Energy storage and new materials eyed for chemistry Nobel
-
Trump unlikely to win Nobel Peace Prize, but who will?
-
Qatar, Turkey to join third day of Gaza peace talks in Egypt
-
Study finds women have higher genetic risk of depression
-
Dolly Parton's sister calls for fan prayers over health issues
-
On Trump's orders, 200 troops from Texas arrive in Illinois
-
Two bodies found, two missing after Madrid building collapse
-
Panthers raise banner as NHL three-peat bid opens with win
-
Nobel physics laureate says Trump cuts will 'cripple' US research
-
UFC star McGregor suspended 18 months over missed drug tests
-
Trump talks up Canada trade deal chances with 'world-class' Carney
-
Ecuador president unharmed after apparent gun attack on motorcade
-
Lyon exact revenge on Arsenal, Barca thrash Bayern in women's Champions League
-
Trump says 'real chance' to end Gaza war as Israel marks attacks anniversary
-
Gerrard brands failed England generation 'egotistical losers'
-
NFL fines Cowboys owner Jones $250,000 over gesture to fans
-
Bengals sign veteran quarterback Flacco after Burrow injury
-
New prime minister inspires little hope in protest-hit Madagascar
-
Is Trump planning something big against Venezuela's Maduro?
-
EU wants to crack down on 'conversion therapy'
-
French sex offender Pelicot says man who abused ex-wife knew she was asleep
-
Trump says 'real chance' to end Gaza war as Israel marks Oct 7 anniversary
-
UK prosecutors to appeal dropped 'terrorism' case against Kneecap rapper
-
Spain, Inter Miami star Alba retiring at end of season
-
EU targets foreign steel to rescue struggling sector
-
Trump talks up Canada deal chances with visiting PM
-
Knight rides her luck as England survive Bangladesh scare
-
Pro-Gaza protests flare in UK on anniversary of Hamas attack
-
Top rugby unions warn players against joining rebel R360 competition
-
Outcast Willis 'not overthinking' England absence despite Top 14 clean sweep
-
Trump says 'real chance' of Gaza peace deal
-
Macron urged to quit to end France political crisis
-
No.1 Scheffler seeks three-peat at World Challenge
-
Canadian PM visits Trump in bid to ease tariffs
-
Stocks falter, gold shines as traders weigh political turmoil
-
Senators accuse US attorney general of politicizing justice
-
LeBron's 'decision of all decisions' a PR stunt

Google AI tool predicts danger of genetic mutations
Researchers at Google DeepMind, the tech giant's artificial intelligence arm, on Tuesday introduced a tool that predicts whether genetic mutations are likely to cause harm, a breakthrough that could help research into rare diseases.
The findings are "another step in recognising the impact that AI is having in the natural sciences," said Pushmeet Kohli, vice president for research at Google DeepMind.
The tool focuses on so-called "missense" mutations, where a single letter of the genetic code is affected.
A typical human has 9,000 such mutations throughout their genome; they can be harmless or cause diseases such as cystic fibrosis or cancer, or damage brain development.
To date, four million of these mutations have been observed in humans, but only two percent of them have been classified, either as disease-causing or benign.
In all, there are 71 million such possible mutations. The Google DeepMind tool, called AlphaMissense, reviewed these mutations and was able to predict 89 percent of them, with 90 percent accuracy.
A score was assigned to each mutation, indicating the risk of it causing disease (otherwise referred to as pathogenic).
The result: 57 percent were classified as probably benign, and 32 percent as probably pathogenic -- the remainder being uncertain.
The database was made public and available to scientists, and an accompanying study was published on Tuesday in the journal Science.
AlphaMissense demonstrates "superior performance" than previously available tools, wrote experts Joseph Marsh and Sarah Teichmann in an article also published in Science.
"We should emphasize that the predictions were never really trained or never really intended to be used for clinical diagnosis alone," said Jun Cheng of Google DeepMind.
"However, we do think that our predictions can potentially be helpful to increase the diagnosed rate of rare disease, and also potentially to help us find new disease-causing genes," Cheng added.
Indirectly, this could lead to the development of new treatments, the researchers said.
The tool was trained on the DNA of humans and closely-related primates, enabling it to recognize which genetic mutations are widespread.
Cheng said the training allowed the tool to input "millions of protein sequences and learns what a regular protein sequence looks like."
It then could identify a mutation and its potential for harm.
Cheng compared the process to learning a language.
"If we substitute a word from an English sentence, a person that is familiar with English can immediately see whether this word substitution will change the meaning of the sentence or not."
A.Ammann--VB